Knight Alzheimer Disease Research Center Clinical Trials Unit

Washington University School of Medicine in St. Louis

What is the Knight ADRC Clinical Trials Unit?

The Washington University in St. Louis Knight Alzheimer Disease Research Center (ADRC) Clinical Trials Unit is one of more than 80 GAP-Net sites working with the Global Alzheimer’s Platform Foundation to accelerate Alzheimer disease clinical research. By volunteering for a study, you join the fight to prevent or cure Alzheimer disease and impact the future of medicine.

“The Knight ADRC Clinical Trials Unit works with our amazing research volunteers to conduct clinical trials for the most promising new drugs for the treatment of Alzheimer disease and other dementias. Together, we are moving towards a world without Alzheimer disease and other dementias.”

—Joy Snider, MD, PhD, Professor of Neurology
Director of the Knight ADRC Clinical Trials Unit

By the Numbers:

30 years of experience

100 clinical trials

5,300 participants

Alzheimer in Missouri:

1 in 8 people over age 65

110,000 people currently

130,000 people by 2025

Studies at the Knight ADRC Clinical Trials Unit

If you are interested in learning more about clinical trials studying investigational medicines to delay or slow the progression of Alzheimer disease, please contact us. You may choose to participate in a study:

  • To learn more about your personal health condition
  • To potentially have access to medications that may alleviate your memory loss or symptoms of Alzheimer disease
  • To help future generations or honor those who have had the disease
  • To be part of the team that is helping to find effective therapies or treatments
KACTU
Address

600 S. Taylor Avenue
Suite 111
St. Louis, MO 63110

Contact

Office :  (314) 273-3866 


Hours

Monday-Friday, 8am - 5pm